Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity
Purpose: The authors report three separate cases of type 1 retinopathy of prematurity (ROP) treated with intravitreal bevacizumab before, or at 34 weeks postmenstrual age (PMA), with subsequent development of secondary glaucoma. Observations: All three cases involve patients born ≤24 weeks and meeti...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2024-12-01
|
| Edice: | American Journal of Ophthalmology Case Reports |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2451993624001415 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|